AnalystsAndrew S. FeinAndrew S. Fein's Stock Forecasts
AnalystsAndrew S. Fein
Sectors:
Industries:
Analyst Ranking
Top 39%
#1920 out of 4995 analysts
Average Return
+13.68%
Win Rate
100%7 out of 7
Risk vs Reward
Poor
Good
Andrew S. Fein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Prothena Corp Public Ltd CoPRTA | +24.75% | $7.03 | $8.77 | 2025-08-04 - 2025-08-22 | Buy |
Day One Biopharmaceuticals IncDAWN | +24.14% | $5.80 | $7.20 | 2025-08-05 - 2025-08-22 | Buy |
Arvinas IncARVN | +17.31% | $6.24 | $7.32 | 2025-08-06 - 2025-08-22 | Buy |
Palvella Therapeutics IncPVLA | +12.94% | $47.30 | $53.42 | 2025-08-14 - 2025-08-22 | Buy |
Insmed IncINSM | +7.33% | $122.87 | $131.88 | 2025-08-12 - 2025-08-22 | Buy |
Andrew S. Fein Analyst Color
Get additional color on Andrew S. Fein's coverage of popular stocks
Andrew S. Fein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Savara IncSVRA | 1 | Buy | $5.00 | +58.23% | Upgrades | 8 days ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $75.00 | +40.40% | Maintains | 8 days ago |
Insmed IncINSM | 1 | Buy | $240.00 | +81.98% | Maintains | 10 days ago |
Arvinas IncARVN | 1 | Buy | $18.00 | +145.90% | Maintains | 16 days ago |
Day One Biopharmaceuticals IncDAWN | 1 | Buy | $25.00 | +247.22% | Maintains | 17 days ago |
Prothena Corp Public Ltd CoPRTA | 1 | Buy | $14.00 | +59.64% | Reiterates | 18 days ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | $478.00 | +20.98% | Maintains | 18 days ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.